¾Æ½Ã¾ÆÅÂÆò¾çÀÇ Àý´ÜÇü RNA Á¦Á¶¿Í Çõ½Å Çù¾÷À¸·ÎÀÇ ¸íÈ®ÇÑ °æ·Î
ÇÔ²², ¿¬°áµÇ¾î, °øµ¿À¸·Î RNA ÀǾàÀÇ º¯È¸¦ ÃËÁø
RNA Leaders´Â À¯·´¡¤¹Ì±¹¿¡¼ÀÇ Å« ¼º°ø¿¡ ÀÌ¾î ¾Æ½Ã¾ÆÅÂÆò¾ç¿¡ ÁøÃâ

ÇöÀç °¡Àå ¿ì¼öÇÑ RNA ÀÎÀç·ÎºÎÅÍ ÆÄ¾Ç
RNA Leaders ÇÁ·Î±×·¥Àº Àå¼â RNA¡¤´Ü¼â RNA ½ºÆåÆ®·³ Àüü¿¡¼ »ó¼¼ÇÑ °³¹ß Àü·«, µ¿Çâ, ±â¼ú ¿Ü¿¡ ´ÙÀ½ ÁßÁ¡ ºÐ¾ß¸¦ Æ÷ÇÔÇÑ °úÇÐ Æ®·¢ÀÌ Æ¯Â¡ÀÔ´Ï´Ù.
mRNA Vaccine & Therapeutics
mRNA ¹é½Å¡¤mRNA ÀǾà
- Clinical data beyond infectious disease areas, such as oncology & rare diseases
Á¾¾ç ¹× Èñ±ÍÁúȯ µî °¨¿°Áõ ÀÌ¿Ü ÀÓ»ó µ¥ÀÌÅÍ - Evaluate mRNA 2.0 modalities – circular RNAs, self-amplifying RNAs and self-replicating RNAs.
mRNA 2.0 ¸ð´Þ¸®Æ¼ÀÇ Æò°¡ - ȯÇü RNA, ÀÚ±â ÁõÆø RNA, Àڱ⠺¹Á¦ RNA
Oligo-Based RNA Therapeutics
¿Ã¸®°í ±â¹Ý RNA ÀǾà
- Development of ASOs and siRNA into the clinic
ASO¡¤siRNAÀÇ ÀÓ»ó °³¹ß - Improve understanding of neurological cardiometabolic and rare diseases
½Å°æ°è, ½ÉÇ÷°ü´ë»ç°è, Èñ±ÍÁúȯÀÇ ÀÌÇØµµ Çâ»ó
Next-Gen RNA
Â÷¼¼´ë RNA
- RNA editing and RNA cell therapy applications
RNA ÆíÁý¡¤RNA ¼¼Æ÷Ä¡·áÀÇ ÀÀ¿ë - Evaluate POCs of regRNAs, tRNAs and other non-coding
regRNA, tRNA, ±âŸ ºñÄÚµå RNA(ncRNA) POC Æò°¡ - Re-emergence of microRNAs applications
miRNA ÀÀ¿ëÀÇ ÀçµîÀå
Àü¿ë ³×Æ®¿öÅ©¿Í Çù¾÷ ±âȸ
°ø½Ä, ºñ°ø½Ä, ºñ±æ µ¥ ¾ø´Â ±âȸ
RNA Leaders¿¡¼´Â ³×Æ®¿öÅ· ±âȸ¸¦ °ÈÇϰí, ¿ÃÇØ 10¿ù¿¡ Á¸Àç°¨À» ÃÖ´ëÇÑ ¹ßÈÖÇϱâ À§ÇØ ´Ù¾çÇÑ ¼Ò¼È ȯ°æÀ» Á¦°øÇÕ´Ï´Ù.
½º¸¶Æ®ÇÑ ³×Æ®¿öÅ© ±¸Ãà
Àü¿ë Ç÷§ÆûÀÎ PartneringOneÀ» ÀÌ¿ëÇϸé Àü·«Àû ÆÄÆ®³Ê ¹× ÁÖ¿ä ÀÇ»ç°áÁ¤ÀÚ¿Í ±³·ùÇϰí, ³×Æ®¿öÅ©¸¦ ¼Õ½±°Ô È®´ëÇÒ ¼ö ÀÖ½À´Ï´Ù.
¿µÇâ·Â ÀÖ´Â 1 on1 ¹ÌÆÃÀ» ¿¹¾àÇÏ¿© RNA LeadersÀÇ ¼º°ø »ç·Ê¿¡ µ¿ÂüÇϼ¼¿ä.
¾ÆÀ̵ð¾î¿Í ¼Ö·ç¼ÇÀÌ ¸¸³ª´Â Àå¼Ò
CEO °£ Ŭ·ÎÁîµå ±×·ì ȯ°æ¿¡¼ ÁÖ¿ä ÆÄ¸¶ ¹× ¾÷°è Àü¹®°¡¿¡°Ô ¾×¼¼½ºÇϰí, ¹ÙÀÌ¿ÀÅ×Å©³î·¯ÁöÀÇ Æò°¡ ÇÁ·Î¼¼½º, IP ÀλçÀÌÆ®, ÀûÀýÇÑ ¾÷°è ÆÄÆ®³Ê µî ºñÁî´Ï½º¿¡ µµ¿òÀÌ µÇ´Â ½Ç¿ëÀû Àü·«À» ȹµæÇÒ ¼ö ÀÖ½À´Ï´Ù.
RNA »çÀ̾𽺿¡¼ ¿µ°¨À» ÁÖ´Â ¿©¼º
RNA ºÐ¾ß ¿©¼ºµéÀÇ ¾÷ÀûÀ» ÃàÇÏÇϰí, ¾÷°èÀÇ Áøº¸¸¦ ÃßÁøÇÏ´Â À̳뺣ÀÌÅÍ ¹× µ¿·á·Î ±¸¼ºµÈ Áö¿ø Ä¿¹Â´ÏƼ¿Í ±³·ùÇÒ ¼ö ÀÖ½À´Ï´Ù.
RNA Leaders USA ... ¼öÄ¡
150+
Attendees
25+
Speakers
15+
Partnering Hours
Âü°¡ ¹æ¹ý
RNA Leaders´Â °¡Àå Çõ½ÅÀûÀÎ ±â¾÷°ú ÀûÀýÇÑ ÆÄÆ®³Ê¸¦ Çѵ¥ ¸ð¾Æ RNA °³¹ßÀÇ ¹Ì·¡¸¦ ÃßÁøÇÕ´Ï´Ù.
´ëÇ¥Àڷμ Âü°¡
2Àϰ£ »ý¸í°úÇÐ ºÐ¾ßÀÇ ¿ì¼öÇÑ ÀÎÀç¿ÍÀÇ À¯ÀÍÇÑ Á¦ÈÞ, Àü¹®°¡ ÆÐ³Î, ³×Æ®¿öÅ· ±âȸ¸¦ ÅëÇØ »õ·Î¿î µ¿·á¿Í ±³·ùÇÒ ¼ö ÀÖ½À´Ï´Ù.
±â¾÷ ÇÁ·¹Á¨Å×À̼Ç
ÀáÀçÀû ÆÄÆ®³ÊÀΠûÁß¿¡°Ô ±Í»çÀÇ ºê·¹ÀÌÅ©½º¸£¸¦ ¼Ò°³ÇÒ ±âȸÀÔ´Ï´Ù.
ÅõÀÚÀڷμ Âü°¡
ÀÚ°ÝÀ» °®Ãá ÅõÀÚÀÚ ¹× ¸®¼Ä¡ ¾Ö³Î¸®½ºÆ®´Â RNA Leaders¿¡ Âü°¡Çϱâ À§ÇÑ ¹«·á µî·Ï ½ÅûÀÌ °¡´ÉÇÕ´Ï´Ù.
¾Æ½Ã¾ÆÅÂÆò¾çÀÇ RNA Leaders¿¡ °í±Þ ÀÇ»ç°áÁ¤ÀÚÀÇ °ü¿©
¾çÁúÀÇ ¸®µå ȹµæ, »ç°í ¸®´õÀÇ ¼Ò°³, ºê·£µåÀÇ °È µî ¾î¶² ¿äûÀ̵ç Çù·ÂÇÏ¿© ºñÁî´Ï½º ¸ñÇ¥ÀÇ ´Þ¼º¿¡ µµ¿òÀÌ µÇ´Â Ä¿½ºÅÒ ½ºÆù¼½Ê ±âȸ¸¦ Á¦¾ÈÇÕ´Ï´Ù.
ÀÚ¼¼ÇÑ »çÇ×Àº (ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀ̼ÇÀ¸·Î ¹®ÀÇÇØÁֽñ⠹ٶø´Ï´Ù.